Notably, there was a significant prognostic difference in stages III-IV between HRG and LRG, whereas no such difference was apparent in stages I-II (Fig. 8 H).
← all excerpts
Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
1
—
—